BRPI0820673A2 - Formulações e composições farmacêuticas de fenilefrina para absorção transmucosal - Google Patents

Formulações e composições farmacêuticas de fenilefrina para absorção transmucosal

Info

Publication number: BRPI0820673A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical compositions; transmucosal absorption; phenylephrine; formulations; phenylephrine formulations
Prior art date: 2007-12-07

Application number

BRPI0820673-2A

Other languages

English (en)

Inventor

John O'mullane

Dennis Nelson

Xiaoming Chen

David Monteith

Joseph P Reo

Jiansheng Wan

Mohammed A Kabir

Original Assignee

Schering Plough Healthcare

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-07

Filing date

2008-12-04

Publication date

2015-06-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40510498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0820673(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-12-04 Application filed by Schering Plough Healthcare filed Critical Schering Plough Healthcare

2015-06-16 Publication of BRPI0820673A2 publication Critical patent/BRPI0820673A2/pt

Links

238000010521 absorption reaction Methods 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 title 1
229960001802 phenylephrine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Immunology (AREA)
Otolaryngology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0820673-2A 2007-12-07 2008-12-04 Formulações e composições farmacêuticas de fenilefrina para absorção transmucosal BRPI0820673A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1222307P	2007-12-07	2007-12-07
PCT/US2008/085523 WO2009076165A1 (en)	2007-12-07	2008-12-04	Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption

Publications (1)

Publication Number	Publication Date
BRPI0820673A2 true BRPI0820673A2 (pt)	2015-06-16

Family

ID=40510498

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0820673-2A BRPI0820673A2 (pt)	2007-12-07	2008-12-04	Formulações e composições farmacêuticas de fenilefrina para absorção transmucosal

Country Status (17)

Country	Link
US (1)	US20090280160A1 (pt)
EP (1)	EP2237767A1 (pt)
JP (1)	JP2011506337A (pt)
KR (1)	KR20100102632A (pt)
CN (1)	CN101938991A (pt)
AR (1)	AR069572A1 (pt)
AU (1)	AU2008335464A1 (pt)
BR (1)	BRPI0820673A2 (pt)
CA (1)	CA2709208A1 (pt)
CL (1)	CL2008003615A1 (pt)
CO (1)	CO6321221A2 (pt)
MX (1)	MX2010006284A (pt)
PE (1)	PE20091084A1 (pt)
RU (1)	RU2010127737A (pt)
TW (1)	TW200932208A (pt)
WO (1)	WO2009076165A1 (pt)
ZA (1)	ZA201004654B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014127118A1 (en)	2013-02-13	2014-08-21	The Procter & Gamble Company	Anise flavored medication
US20190008759A1 (en) *	2014-07-03	2019-01-10	Darren Rubin	Safer and more effective methods of transmucosal delivery for raising blood pressure and stimulating the body
MA41689A (fr) *	2014-10-15	2017-08-22	Bioxcel Corp	Prévention ou traitement de troubles du sommeil au moyen d'une formulation de dexmédétomidine
US12433850B2 (en)	2016-05-05	2025-10-07	Aquestive Therapeutics, Inc.	Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en)	2016-05-05	2022-03-15	Aquestive Therapeutics, Inc.	Pharmaceutical compositions with enhanced permeation
CN122182527A (zh) *	2016-05-05	2026-06-12	阿奎斯蒂弗医疗股份有限公司	增强递送的肾上腺素组合物
US12427121B2 (en)	2016-05-05	2025-09-30	Aquestive Therapeutics, Inc.	Enhanced delivery epinephrine compositions
IL267689B2 (en)	2016-12-31	2025-05-01	Bioxcel Therapeutics Inc	Use of sublingual dexmedetomidine for the treatment of agitation
AU2018208531A1 (en)	2017-01-11	2019-06-13	Ferring B.V.	A fast disintegrating pharmaceutical composition
WO2019021476A1 (ja) *	2017-07-28	2019-01-31	社会医療法人蘇西厚生会まつなみリサーチパーク	アレルギー症状の予防又は治療剤
CN111465391A (zh) *	2017-09-27	2020-07-28	阿奎斯蒂弗医疗股份有限公司	具有增强的递送的肾上腺素和前药的组合物
IL279713B2 (en)	2018-06-27	2025-01-01	Bioxcel Therapeutics Inc	Dexmedetomidine-containing layer compositions and methods for their production
EP3999058A4 (en)	2019-07-19	2023-05-03	Bioxcel Therapeutics, Inc.	TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN
EP4157451B1 (en) *	2020-06-02	2024-12-04	Mohamed Hussein Hamdan	Sublingual formulation for hypotension and syncope
US12286451B2 (en)	2020-11-23	2025-04-29	Medtech Products Inc.	Borate ester complexes of α-hydroxy carboxylic acids and their conjugate base buffers
WO2023076281A1 (en)	2021-10-25	2023-05-04	Aquestive Therapeutics, Inc.	Oral and nasal compositions and methods of treatment
US11806334B1 (en)	2023-01-12	2023-11-07	Bioxcel Therapeutics, Inc.	Non-sedating dexmedetomidine treatment regimens

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3558768A (en) *	1969-12-19	1971-01-26	Sterling Drug Inc	Sustained release pharmaceutical compositions
US4291015A (en) *	1979-08-14	1981-09-22	Key Pharmaceuticals, Inc.	Polymeric diffusion matrix containing a vasodilator
US4427681A (en) *	1982-09-16	1984-01-24	Richardson-Vicks, Inc.	Thixotropic compositions easily convertible to pourable liquids
US5025019A (en) *	1984-04-09	1991-06-18	Analgesic Associates	Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4623664A (en) *	1985-10-31	1986-11-18	University Of Iowa Research Foundation	Oil suspended phenylephrine
US4764378A (en) *	1986-02-10	1988-08-16	Zetachron, Inc.	Buccal drug dosage form
US4792452A (en) *	1987-07-28	1988-12-20	E. R. Squibb & Sons, Inc.	Controlled release formulation
US5085865A (en) *	1989-04-12	1992-02-04	Warner-Lambert Company	Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5133974A (en) *	1989-05-05	1992-07-28	Kv Pharmaceutical Company	Extended release pharmaceutical formulations
DE9190107U1 (de) *	1990-08-07	1993-12-16	Pfizer Inc., New York, N.Y.	Abgabe-Vorrichtung mit durch Grenzflächen-Polymerisation erhaltenen Membranen
US5518730A (en) *	1992-06-03	1996-05-21	Fuisz Technologies Ltd.	Biodegradable controlled release flash flow melt-spun delivery system
US5458879A (en) *	1994-03-03	1995-10-17	The Procter & Gamble Company	Oral vehicle compositions
GB9422571D0 (en) *	1994-11-09	1995-01-04	Whitehall Lab Ltd	Haemorrihoidal compositions and method of use
US5827531A (en) *	1994-12-02	1998-10-27	The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration	Microcapsules and methods for making
NL1005394C1 (nl) *	1996-04-01	1997-10-02	Kokbing Lo	Bevestigingselement en band bevestigd met bevestigingselement.
DE69735552T3 (de) *	1996-12-23	2009-08-13	S.L.A. Pharma Ag	Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz
DE69833000T2 (de) *	1997-09-26	2006-09-07	Noven Pharmaceuticals, Inc., Miami	Bio-klebemittelzusammensetzungen
US6602521B1 (en) *	1998-09-29	2003-08-05	Impax Pharmaceuticals, Inc.	Multiplex drug delivery system suitable for oral administration
US7815937B2 (en) *	1998-10-27	2010-10-19	Biovail Laboratories International Srl	Quick dissolve compositions and tablets based thereon
US6521254B2 (en) *	1998-12-07	2003-02-18	J-Med Pharmaceuticals, Inc.	Single-dose antihistamine/decongestant formulations for treating rhinitis
US6267986B1 (en) *	1999-09-24	2001-07-31	Ranbaxy Laboratories Limited	Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6114346A (en) *	1999-10-22	2000-09-05	Schering Corporation	Treating sleep disorders using desloratadine
AU2277101A (en) *	1999-12-20	2001-07-03	Schering Corporation	Stable extended release oral dosage composition
AU2276801A (en) *	1999-12-20	2001-07-03	Schering Corporation	Extended release oral dosage composition
US6955821B2 (en) *	2000-04-28	2005-10-18	Adams Laboratories, Inc.	Sustained release formulations of guaifenesin and additional drug ingredients
AU2001261744A1 (en) *	2000-05-19	2001-12-03	Npd Llc	Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
WO2003009834A1 (en) *	2000-08-17	2003-02-06	Battey Alyce S	Oral delivery of pharmaceuticals via encapsulation
US20030236275A1 (en) *	2002-06-20	2003-12-25	Schering Corporation	Treatment methods of nasal congestion and nasal obstruction
US6585997B2 (en) *	2001-08-16	2003-07-01	Access Pharmaceuticals, Inc.	Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
WO2003019948A1 (en) *	2001-08-27	2003-03-06	Koninklijke Philips Electronics N.V.	Video data processor
US7163696B2 (en) *	2001-10-11	2007-01-16	Pfizer Inc.	Pharmaceutical formulations
US20030083354A1 (en) *	2001-10-26	2003-05-01	Pediamed Pharmaceuticals, Inc.	Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
US20030114535A1 (en) *	2001-12-14	2003-06-19	Jame Fine Chemicals, Inc.	Dextrochlorpheniramine tannate
US20040122107A1 (en) *	2002-09-13	2004-06-24	Fine Jeffrey R	Method of alleviating barometric-induced symptoms in airline passengers
JP2004121962A (ja) *	2002-10-01	2004-04-22	National Institute Of Advanced Industrial & Technology	ナノバブルの利用方法及び装置
US6979689B2 (en) *	2002-12-20	2005-12-27	Pediamed Pharmaceuticals, Inc.	Compositions and methods for treating upper respiratory congestion
US20040214215A1 (en) *	2003-03-07	2004-10-28	Yu Ruey J.	Bioavailability and improved delivery of alkaline pharmaceutical drugs
US20050152967A1 (en) *	2003-03-28	2005-07-14	Pfab, Lp	Dynamic variable release
US20050026890A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20070219253A1 (en) *	2003-09-17	2007-09-20	Gul Balwani	Decongestant / antihistaminic / expectorant compositions
US20050095288A1 (en) *	2003-11-03	2005-05-05	Andrx Labs, Llc	Decongestant and expectorant tablets
US20050266032A1 (en) *	2003-12-17	2005-12-01	Sovereign Pharmaceuticals, Ltd.	Dosage form containing multiple drugs
US20070110689A1 (en) *	2004-01-15	2007-05-17	Mark Feldschuh	Oral anaesthetic gel
NZ555909A (en) *	2004-12-13	2009-11-27	Mcneil Ppc Inc	Compositions and methods for reducing the degradation of phenylephrine by oxygen
US8318210B2 (en) *	2005-02-28	2012-11-27	Neos Therapeutics, Lp	Compositions and methods of making sustained release liquid formulations
CA2612179C (en) *	2005-06-17	2016-08-02	Aft Pharmaceuticals Limited	A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
US20070141147A1 (en) *	2005-12-21	2007-06-21	Auriga Laboratories, Inc.	Sequential release pharmaceutical formulations
US8940796B2 (en) *	2006-02-21	2015-01-27	Wyeth Llc	Phenylephrine liquid formulations
US20080014274A1 (en) *	2006-07-14	2008-01-17	Wyeth	Enhanced stability phenylephrine liquid compositions
US9005652B2 (en) *	2006-07-25	2015-04-14	Wyeth	Chewable tablet containing phenylephrine
US7378082B1 (en) *	2007-11-05	2008-05-27	Inspire Pharmaceuticals, Inc.	Method for treating allergic rhinitis without adverse effects

2008
- 2008-12-03 PE PE2008002013A patent/PE20091084A1/es not_active Application Discontinuation
- 2008-12-04 BR BRPI0820673-2A patent/BRPI0820673A2/pt not_active IP Right Cessation
- 2008-12-04 RU RU2010127737/15A patent/RU2010127737A/ru not_active Application Discontinuation
- 2008-12-04 JP JP2010537049A patent/JP2011506337A/ja not_active Withdrawn
- 2008-12-04 MX MX2010006284A patent/MX2010006284A/es not_active Application Discontinuation
- 2008-12-04 KR KR1020107014733A patent/KR20100102632A/ko not_active Withdrawn
- 2008-12-04 US US12/328,429 patent/US20090280160A1/en not_active Abandoned
- 2008-12-04 EP EP08858399A patent/EP2237767A1/en not_active Withdrawn
- 2008-12-04 AR ARP080105286A patent/AR069572A1/es not_active Application Discontinuation
- 2008-12-04 CN CN2008801263844A patent/CN101938991A/zh active Pending
- 2008-12-04 AU AU2008335464A patent/AU2008335464A1/en not_active Abandoned
- 2008-12-04 TW TW097147189A patent/TW200932208A/zh unknown
- 2008-12-04 WO PCT/US2008/085523 patent/WO2009076165A1/en not_active Ceased
- 2008-12-04 CA CA2709208A patent/CA2709208A1/en not_active Abandoned
- 2008-12-04 CL CL2008003615A patent/CL2008003615A1/es unknown
2010
- 2010-07-01 ZA ZA2010/04654A patent/ZA201004654B/en unknown
- 2010-07-07 CO CO10082162A patent/CO6321221A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20090280160A1 (en)	2009-11-12
MX2010006284A (es)	2010-09-07
ZA201004654B (en)	2011-03-30
RU2010127737A (ru)	2012-01-20
PE20091084A1 (es)	2009-07-23
CO6321221A2 (es)	2011-09-20
EP2237767A1 (en)	2010-10-13
JP2011506337A (ja)	2011-03-03
KR20100102632A (ko)	2010-09-24
AU2008335464A1 (en)	2009-06-18
CL2008003615A1 (es)	2009-10-16
AR069572A1 (es)	2010-02-03
CN101938991A (zh)	2011-01-05
TW200932208A (en)	2009-08-01
WO2009076165A1 (en)	2009-06-18
CA2709208A1 (en)	2009-06-18

Legal Events

Date	Code	Title	Description
2015-09-01	B25D	Requested change of name of applicant approved	Owner name: MSD CONSUMER CARE, INC. (US)
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
LTC2140867I2 (lt)	2018-11-12	Farmacinė kompozicija
ZA201004654B (en)	2011-03-30	Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption
LTPA2018014I1 (lt)	2018-12-10	Farmacinė kompozicija 514
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
DK3492069T3 (da)	2022-03-14	Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0913379A2 (pt)	2015-11-24	formulações farmacêuticas sólidas compreendendo bibw 2992
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
BRPI0819218A2 (pt)	2015-05-05	Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0919466A2 (pt)	2015-12-01	composição farmacêutica para liberação modificada
BRPI0908596A2 (pt)	2015-09-15	formulação e composição farmacêutica de liberação prolongada
EP2191826A4 (en)	2010-09-15	PHARMACEUTICAL COMPOSITION
EP2124556A4 (en)	2009-12-30	PHARMACEUTICAL COMPOSITIONS
ATE493119T1 (de)	2011-01-15	Pharmazeutische zusammensetzung
DK1884242T3 (da)	2013-05-06	Farmaceutisk sammensætning omfattende lurasidon
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
DE602008005137D1 (de)	2011-04-07	Chinolonverbindung und pharmazeutische zusammensetzung
BRPI0912656A2 (pt)	2016-01-26	formulação farmacêutica sólida
BRPI0812000A2 (pt)	2014-11-18	Métodos e composições para administração de oxibutinina